Your shopping cart is currently empty

Synonyms: Uridine 5'-diphosphoglucose disodium sal, UDP-α-D-Glucose sodium salt, UDP-Glucose sodium salt, UDPG sodium salt

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 100 mg | $42 | In Stock | In Stock | |
| 500 mg | $95 | In Stock | In Stock |
| Description | Uridine 5′-diphosphoglucose disodium salt (UDP-glucose) is a natural product and a P2Y14 receptor agonist (EC50 = 0.35 μM) with endogenous activity and selectivity. It is used for studying mechanisms related to cardiac inflammation following myocardial infarction/reperfusion injury. |
| Targets & IC50 | P2Y14 receptor:0.35 μM (EC50) |
| In vitro | Methods: Neutrophils were treated with Uridine 5′-diphosphoglucose disodium salt (0-100 μM) for 24 hours. P2Y14 receptor expression and cell apoptosis were detected. Results: Uridine 5′-diphosphoglucose disodium salt upregulated P2Y14 receptor expression and induced neutrophil apoptosis. [1] Methods: Mouse neutrophils were incubated with PPTN alone or combined with UDP-Glu (1 μM) for 24 hours. Cell viability was detected by CCK-8 assay, apoptosis and polarization (N1/N2) were detected by flow cytometry, migration ability was detected by Transwell, and P2Y14 expression was detected by Western Blot. Results: PPTN significantly reversed UDP-Glu-induced decreased cell viability, increased apoptosis, and inhibited migration, promoted N2 polarization, and reduced inflammatory factor expression. [2] |
| Synonyms | Uridine 5'-diphosphoglucose disodium sal, UDP-α-D-Glucose sodium salt, UDP-Glucose sodium salt, UDPG sodium salt |
| Molecular Weight | 610.27 |
| Formula | C15H22N2Na2O17P2 |
| Cas No. | 28053-08-9 |
| Smiles | [Na+].[Na+].OC[C@@H](OP(=O)(OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1ccc(=O)[nH]c1=O)OP([O-])([O-])=O)[C@@H](O)[C@H](O)[C@@H](O)C=O |
| Relative Density. | no data available |
| Storage | Store under nitrogen,Keep away from moisture Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | H2O: 125 mg/mL (204.83 mM), Sonication is recommended. DMSO: 128.75 mg/mL (210.97 mM) | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (8.19 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
H2O/DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.